Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Comprehensive characterisation of patients with colorectal cancer and permanently liver-limited disease.

Created on 15 Nov 2026

Authors

F Salva, I Baraibar, N Saoudi, J Ros, A Mas, M R Castells, C Salvà de Torres, R Comas, E García-Galera, C Vaghi, A García, L Nonell, A Vivancos, J Tabernero, E Elez

Published in

ESMO gastrointestinal oncology. Volume 14. Pages 100434. Epub Nov 05, 2026.

Abstract

Metastatic colorectal cancer (mCRC) shows organ-specific patterns of dissemination. Approximately 20% of patients develop disease confined to the liver throughout the course. Early recognition and characterisation of this phenotype may inform therapeutic stratification and improve outcomes.
We retrospectively analysed patients with unresectable mCRC. Patients were classified by metastatic distribution into liver-limited, liver plus extrahepatic, or extrahepatic-only disease. Clinicopathological features, genomic alterations assessed by next-generation sequencing, and immune contexture based on a 12-gene signature from the primary tumour were evaluated.
Among 1026 eligible patients, 20% had permanently liver-limited disease, 51% had both hepatic and extrahepatic involvement, and 29% had extrahepatic-only metastases. Liver-limited cases were enriched for synchronous presentation and nonrectal primaries, with a lower prevalence of KRAS mutations (P = 0.013). Tumours with liver plus extrahepatic dissemination showed greater genetic alterations across multiple cancer hallmarks (P < 0.05). Immune profiling revealed a markedly lower proportion of cold phenotypes in extrahepatic-only disease compared with liver-involved cases (P = 0.041). Despite similar genomic profiles, extrahepatic-only disease was associated with improved overall survival.
Permanent liver-limited mCRC defines a clinically and biologically distinct subgroup characterised by synchronous onset, nonrectal primaries, and reduced KRAS mutation frequency. The immune landscape of the primary tumour was associated with metastatic organ pattern.

PMID:
43034718
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement